| |
|
|
|
Xtalks, online
2023 -7-11
During this session, featured speaker Brandon Bogdalek, will interview two industry leading panelists. The panelists will discuss important factors to consider when evaluating off-the-shelf (OTS) drug delivery platforms vs. developing a novel solution. Key topics will include cost and pricing impacts, timeline to commercialization, as well as R&D, human factors and user needs considerations. Panelists will share their perspectives with respect to choosing OTS solutions or building a novel drug delivery platform.
Discover the factors to consider when evaluating off-the-shelf (OTS) vs. novel drug delivery solutions. Register now.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
(Moderator) Brandon Bogdalek, Vice President, Demand Generation, Veranex Michelle Howard-Sparks, VP, Product Development, Eyepoint Therapeutics Valerie Fenster, Director, Packaging and Human Factors Engineering, Akero Therapeutics
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2023 -7-11
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|